Trends in Morbidity and Mortality after Hepatic Resection for Hepatocellular Carcinoma: An Institute's Experience with 625 Patients

Journal of the American College of Surgeons

Volumn 204, Issue 4, 2007, Pages 580-587

  Taketomi, Akinobu ^a   Kitagawa, Dai ^a   Itoh, Shinji ^a   Harimoto, Norifumi ^a   Yamashita, Yo ichi ^a   Gion, Tomonobu ^a   Shirabe, Ken ^a   Shimada, Mitsuo ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASCITES; BLEEDING; BLOOD TRANSFUSION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK; RISK FACTOR;

AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HOSPITAL MORTALITY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 33947207478     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2007.01.035     Document Type: Article

References (26)

1. Matsumata T., Kanematsu T., Shirabe K., et al. Decreased morbidity and mortality rates in surgical patients with hepatocellular carcinoma. Br J Surg 77 (1990) 677-680
2. Lai E.C., Fan S.T., Lo C.M., et al. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 221 (1995) 291-298
3. Nagasue N., Kohno H., Chang Y.C., et al. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 217 (1993) 375-384
4. Takenaka K., Kawahara N., Yamamoto K., et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 131 (1996) 71-76
5. Yamanaka N., Takata M., Tanaka T., et al. Evolution of and obstacles in surgical treatment for hepatocellular carcinoma over the last 25 years: differences over four treatment eras. J Gastroenterol 35 (2000) 613-621
6. Makuuchi M. Remodeling the surgical approach to hepatocellular carcinoma. Hepatogastroenterology 49 (2002) 36-40
7. Belghiti J., Hiramatsu K., Benoist S., et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191 (2000) 38-46
8. Belghiti J., Regimbeau J.M., Durand F., et al. Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology 49 (2002) 41-46
9. Wei A.C., Tung-Ping Poon R., Fan S.T., and Wong J. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg 90 (2003) 33-41
10. Kanematsu T., Takenaka K., Matsumata T., et al. Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg 199 (1984) 51-56
11. Yamanaka N., Okamoto E., Oriyama T., et al. A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg 219 (1994) 342-346
12. Shimada M., Takenaka K., Fujiwara Y., et al. Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg 85 (1998) 195-198
13. Farges O., Malassagne B., Flejou J.F., et al. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 229 (1999) 210-215
14. Torzilli G., Makuuchi M., Inoue K., et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way?. A prospective analysis of our approach. Arch Surg 134 (1999) 984-992
15. Melendez J., Ferri E., Zwillman M., et al. Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg 192 (2001) 47-53
16. Papadimitriou J.D., Fotopoulos A.C., Prahalias A.A., et al. The impact of new technology on hepatic resection for malignancy. Arch Surg 136 (2001) 1307-1313
17. Yamashita Y., Hamatsu T., Rikimaru T., et al. Bile leakage after hepatic resection. Ann Surg 233 (2001) 45-50
18. Yamashita Y., Shimada M., Hamatsu T., et al. Effects of preoperative steroid administration on surgical stress in hepatic resection: prospective randomized trial. Arch Surg 136 (2001) 328-333
19. Imamura H., Seyama Y., Kokudo N., et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138 (2003) 1198-1206
20. Das B.C., Isaji S., and Kawarada Y. Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice. World J Surg 25 (2001) 266-272
21. Shimada M., Matsumata T., Shirabe K., et al. Effect of nafamostat mesilate on coagulation and fibrinolysis in hepatic resection. J Am Coll Surg 178 (1994) 498-502
22. Malassagne B., Cherqui D., Alon R., et al. Safety of selective vascular clamping for major hepatectomies. J Am Coll Surg 187 (1998) 482-486
23. Shimada M., Matsumata T., Akazawa K., et al. Estimation of risk of major complications after hepatic resection. Am J Surg 167 (1994) 399-403
24. Plevris J.N., Dhariwal A., Elton R.A., et al. The platelet count as a predictor of variceal hemorrhage in primary biliary cirrhosis. Am J Gastroenterol 90 (1995) 959-961
25. Cioni G., Tincani E., D'Alimonte P., et al. Relevance of reduced portal flow velocity, low platelet count and enlarged spleen diameter in the non-invasive diagnosis of compensated liver cirrhosis. Eur J Med 2 (1993) 408-410
26. Luo J.C., Hwang S.J., Chang F.Y., et al. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C. Hepatogastroenterology 49 (2002) 478-481